Literature DB >> 16217064

Transverse sinus stenoses persist after normalization of the CSF pressure in IIH.

F Bono1, C Giliberto, C Mastrandrea, D Cristiano, A Lavano, F Fera, A Quattrone.   

Abstract

BACKGROUND: Bilateral transverse sinus (TS) stenosis has been found in more than 90% of patients with idiopathic intracranial hypertension (IIH).
OBJECTIVE: To evaluate whether TS stenosis changed after normalization of CSF pressure in patients with IIH during medical treatment.
METHODS: Fourteen consecutive patients with IIH with bilateral TS stenosis on cerebral MR venography (MRV) during the medical treatment were studied. Patients were followed for over a 6-year period. During the follow-up, patients underwent repeated lumbar punctures (LPs) and cerebral MRV. MRV was always performed before each LP.
RESULTS: TS stenosis persisted in all the patients during the follow-up. In 9 of 14 (64%) patients with IIH, CSF pressure normalized during medical treatment.
CONCLUSIONS: Transverse sinus (TS) stenoses, as revealed by MR venography, persist in patients with idiopathic intracranial hypertension after normalization of CSF pressure, suggesting the lack of a direct relationship between the caliber of TS and CSF pressure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16217064     DOI: 10.1212/01.wnl.0000178889.63571.e5

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

Review 1.  Pseudotumor cerebri.

Authors:  Pietro Spennato; Claudio Ruggiero; Raffaele Stefano Parlato; Maria Consiglio Buonocore; Antonio Varone; Emilio Cianciulli; Giuseppe Cinalli
Journal:  Childs Nerv Syst       Date:  2010-08-19       Impact factor: 1.475

Review 2.  [Characteristic neurological features, differential diagnostic criteria and medicinal treatment of idiopathic intracranial hypertension].

Authors:  K-D Willenborg; W Nacimiento
Journal:  Ophthalmologe       Date:  2015-10       Impact factor: 1.059

Review 3.  Current concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults.

Authors:  Jane W Chan
Journal:  J Neurol       Date:  2017-01-31       Impact factor: 4.849

4.  Transverse venous sinus stenosis and intracranial hypertension: evidence for which comes first.

Authors:  R Simister; J V Bowler; P L Wilson; B Unwin; D Kidd
Journal:  J Neurol       Date:  2007-11-14       Impact factor: 4.849

5.  The relationship of transverse sinus stenosis to bony groove dimensions provides an insight into the aetiology of idiopathic intracranial hypertension.

Authors:  S E J Connor; M A Siddiqui; V R Stewart; E A M O'Flynn
Journal:  Neuroradiology       Date:  2008-07-12       Impact factor: 2.804

6.  Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension.

Authors:  Laura J Edwards; Basil Sharrack; Azza Ismail; Christopher R Tench; Bruno Gran; Samish Dhungana; Johannes Brettschneider; Hayrettin Tumani; Cris S Constantinescu
Journal:  Am J Clin Exp Immunol       Date:  2013-10-16

Review 7.  Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression?

Authors:  Roberto De Simone; Angelo Ranieri; Chiara Fiorillo; Leonilda Bilo; Vincenzo Bonavita
Journal:  Neurol Sci       Date:  2010-02-25       Impact factor: 3.307

8.  Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions.

Authors:  R M Ahmed; M Wilkinson; G D Parker; M J Thurtell; J Macdonald; P J McCluskey; R Allan; V Dunne; M Hanlon; B K Owler; G M Halmagyi
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-28       Impact factor: 3.825

9.  Reversible transverse sinus collapse in a patient with idiopathic intracranial hypertension.

Authors:  Halil Onder; Rahsan Gocmen; Yasemin Gursoy-Ozdemir
Journal:  BMJ Case Rep       Date:  2015-05-15

10.  Bilateral transverse sinus stenosis and idiopathic intracranial hypertension without papilledema in chronic tension-type headache.

Authors:  F Bono; D Messina; C Giliberto; D Cristiano; G Broussard; S D'Asero; F Condino; L Mangone; C Mastrandrea; F Fera; A Quattrone
Journal:  J Neurol       Date:  2008-05-06       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.